At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Our solution for continuous tableting lines is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:
Visualizzazione di 4 su 10

The ConsiGma® CF20 test rig is a standalone module that allows you to characterize the feeding behavior of your products during the early stages of R&D.

An indispensable part of the ConsiGma portfolio, the Conductor control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line

A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.
Designed to achieve optimal blending results, the ConsiGma® DB modules facilitate the testing of dosing and blending operations and can be integrated with any continuous up- or downstream process.

Mentre la domanda dei consumatori per le bevande più innovative nel settore della salute e del benessere continua a evolversi e a crescere, GEA aiuta i produttori a lanciare sul mercato nuovi prodotti in modo sicuro, efficiente e su larga scala.

Al settore manifatturiero viene richiesto di utilizzare meno risorse, puntare su tecnologie avanzate e mantenere le attrezzature in piena efficienza più a lungo. In GEA, questo sta cambiando il modo in cui nasce l’innovazione: ingegneria, comprensione delle esigenze dei clienti, competenze digitali e assistenza si integrano sin dalle prime fasi, quando una soluzione può ancora essere plasmata nella sua essenza.